摘要 |
The invention provides compounds that inhibit epoxide hydrolase in therapeutic applications for treating hypertension. A preferred class of compounds for practicing the invention have the structure shown by Formula I wherein Z is oxygen or sulfur, W is carbon phosphorous or sulfur, X and Y is each independently nitrogen, oxygen, or sulfur, and X can further be carbon, at least one of R<SUB>1</SUB>-R<SUB>4 </SUB>is hydrogen, R<SUB>2 </SUB>is hydrogen when X is nitrogen but is not present when X is sulfur or oxygen, R<SUB>4 </SUB>is hydrogen when Y is nitrogen but is not present when Y is sulfur or oxygen, R<SUB>1 </SUB>and R<SUB>3 </SUB>is each independently C<SUB>1</SUB>-C<SUB>20 </SUB>substituted or unsubstituted alkyl, cycloalkyl, aryl, acyl, or heterocyclic.
|